Helminski v. Ayerst Laboratories

766 F.2d 208, 18 Fed. R. Serv. 321, 1985 U.S. App. LEXIS 30700
CourtCourt of Appeals for the Sixth Circuit
DecidedJune 25, 1985
Docket83-1726
StatusPublished
Cited by25 cases

This text of 766 F.2d 208 (Helminski v. Ayerst Laboratories) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Helminski v. Ayerst Laboratories, 766 F.2d 208, 18 Fed. R. Serv. 321, 1985 U.S. App. LEXIS 30700 (6th Cir. 1985).

Opinion

766 F.2d 208

18 Fed. R. Evid. Serv. 321

Catherine and Frank HELMINSKI, as Next Friends of Minor Hugh
Helminski, Plaintiffs-Appellants,
v.
AYERST LABORATORIES, A DIVISION OF AMERICAN HOME PRODUCTS
CORP., a Delaware Corporation, Defendant-Appellee.

No. 83-1726.

United States Court of Appeals,
Sixth Circuit.

Argued Feb. 13, 1985.
Decided June 25, 1985.

Thomas H. Bleakley, Brian J. McKeen (argued), Detroit, Mich., for plaintiffs-appellants.

Konrad D. Kohl (argued), Michael L. Updike, Altero J. Alteri, Farmington Hills, Mich., for defendant-appellee.

Before ENGEL and KEITH, Circuit Judges, and CELEBREZZE, Senior Circuit Judge.

CELEBREZZE, Senior Circuit Judge.

Plaintiffs-appellants Catherine and Frank Helminski, as Next Friends of their minor son, Hugh, brought this products liability suit against defendant-appellee Ayerst Laboratories. The Helminskis contended that Hugh's in utero exposure to Fluothane,1 a surgical anesthetic manufactured by Ayerst, resulted in injury to his developing nervous system. Specifically, they alleged that Ayerst Laboratories was negligent in testing and marketing Fluothane without warning of potential injury to a fetus, breached express and implied warranties that the product was safe for use by operating room personnel in the first trimester of pregnancy, committed fraud and deceit in marketing Fluothane, and should be held strictly liable for marketing the product. The essence of Ayerst's defense was that Hugh's condition was not the result of in utero exposure to its product. After a six-day trial, the jury returned a verdict of no cause of action. The district court denied the Helminskis' subsequent motion for a new trial. From this ruling, the Helminskis appeal.

Catherine Helminski was a certified registered nurse anesthetist. During the entire term of her pregnancy with Hugh, she was employed full-time administering anesthesia to patients undergoing surgery. Fluothane was used in over 90% of the 148 surgical procedures in which Mrs. Helminski administered anesthesia. Both parties agree that during the course of the pregnancy Mrs. Helminski was exposed to Fluothane, although they disagree as to the extent of such exposure.

Born in September 1966, Hugh began to exhibit signs of developmental retardation at an early age. For example, he had not yet begun to speak as he neared the age of three. Eventually, physicians determined that Hugh was autistic. As a result of this condition, Hugh requires 24-hour a day care; he does not speak, is not toilet trained, and has an extremely low IQ. Hugh's arrested neurological development is permanent and irreversible.

The Helminskis raise three issues on appeal. First, they contend that certain references by the trial judge and defense counsel concerning Fluothane's alleged claim-free history were improper and prejudicial. Second, the Helminskis challenge the district court's decision, which was rendered after they had presented most of their witnesses, to bifurcate the proceedings into separate trials on liability and damages. Finally, the Helminskis argue that Hugh's exclusion from the courtroom during the liability portion of the proceedings infringed upon his Seventh Amendment right to a jury trial and his Fifth Amendment right to due process of law.

I.

The trial court's introductory remarks to the jury, made during voir dire, included the following:

The defendant contends that this is the first case in which it is claimed that exposure by a pregnant woman to this particular drug in question ... resulted in the birth of a child suffering injury.

Similarly, in his opening statement, counsel for Ayerst indicated that the case was the first "anyplace" in which a party alleged that a pregnant woman's exposure to Fluothane in the operating room resulted in "birth to an autistic child." The Helminskis' counsel failed to object to either statement. On appeal, the Helminskis assert that such comments were prejudicial and warrant a new trial.

A party may not assert as error the introduction of evidence unless a timely objection is made. Fed.R.Evid. 103(a)(1); see Kokesh v. American Steamship Co., 747 F.2d 1092, 1094-95 (6th Cir.1984). Although a court may review the introduction of evidence in the absence of an objection if it constitutes plain error and affects a party's substantial rights, Fed.R.Evid. 103(d), an important consideration in determining whether appellate review is appropriate is the number of times the allegedly improper evidence was elicited without objection, see United States v. Martin, 757 F.2d 770, 771 (6th Cir.1985) (review under plain error rule discretionary).

In this case, counsel for the Helminskis failed to object to the statements of both the trial judge and Ayerst's counsel. Moreover, on two occasions defense counsel asked expert witnesses if they were aware of any other allegations that Fluothane's use resulted in birth defects; the record discloses that no objections were made. In light of the complete failure of counsel to bring before the trial court his objection on this matter, we do not believe that he perceived the issue as one which affected the substantial rights of his client. Cf. Wainwright v. Witt, --- U.S. ----, ----, ----, 105 S.Ct. 844, 858, 859 n. 4, 83 L.Ed.2d 841 (1985) (Stevens, J., concurring). Nor do we believe, as plaintiffs' counsel asserts on appeal, that his failure to object should be excused because he feared that an objection would emphasize the error before the jury. While under limited circumstances an objection might only exacerbate an error in admission of testimony, Brown v. Walter, 62 F.2d 798, 799-800 (2d Cir.1933), counsel is generally not excused from bringing an objection to the court's attention, see Bryant v. Consolidated Rail Corp., 672 F.2d 217, 218-19 (1st Cir.1982). Any other general rule would eviscerate Fed.R.Evid. 103(a)(1). We conclude that, in fact, there was no reason to believe that a timely objection would emphasize Fluothane's alleged claim-free history before the jury. Accordingly, the Helminskis have failed to preserve for review their challenge to the comments related to Fluothane's alleged claim-free history.

II.

Following the testimony of the Helminskis' final expert witness, counsel announced his intention to call Hugh as a witness despite a previous agreement to present Hugh to the jury only in a videotape.2 Ayerst objected, arguing that Hugh's condition had already been described graphically and, moreover, that there was no dispute concerning the nature of his problems. Essentially, Ayerst perceived that Hugh's presence in the courtroom would prejudice the jury against its case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ogle v. Jones
E.D. Tennessee, 2024
Gauthier v. Gauthier
2024 Ohio 266 (Ohio Court of Appeals, 2024)
Crow v. Brezenski
D. Kansas, 2022
In re M-I L.L.C.
505 S.W.3d 569 (Texas Supreme Court, 2016)
Mainor v. Nault
101 P.3d 308 (Nevada Supreme Court, 2004)
In the Interest of Doe Children
76 P.3d 578 (Hawaii Intermediate Court of Appeals, 2003)
Green v. North Arundel Hospital Association, Inc.
785 A.2d 361 (Court of Appeals of Maryland, 2001)
Wozniak v. New Britain General Hosp., No. X03cv950502560s (Jun. 1, 2001)
2001 Conn. Super. Ct. 7648 (Connecticut Superior Court, 2001)
Green v. Milbar Hydrotest
Fifth Circuit, 2000
Cary by and Through Cary v. Oneok, Inc.
1997 OK 60 (Supreme Court of Oklahoma, 1997)
Evans v. Connecticut
168 F.R.D. 118 (D. Connecticut, 1996)
Reems Ex Rel. Reems v. St. Joseph's Hospital & Health Center
536 N.W.2d 666 (North Dakota Supreme Court, 1995)
Province v. Center for Women's Health & Family Birth
20 Cal. App. 4th 1673 (California Court of Appeal, 1993)
Lagudi v. Long Island Railroad
775 F. Supp. 73 (E.D. New York, 1991)
Bremner Ex Rel. Bremner v. Charles
799 P.2d 188 (Court of Appeals of Oregon, 1990)
United States v. Thomas P. Rachael
866 F.2d 431 (Sixth Circuit, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
766 F.2d 208, 18 Fed. R. Serv. 321, 1985 U.S. App. LEXIS 30700, Counsel Stack Legal Research, https://law.counselstack.com/opinion/helminski-v-ayerst-laboratories-ca6-1985.